Starpharma, Stiefel to Collaborate on Dermal Products

Australia’s Starpharma has signed a research agreement with Stiefel Laboratories to apply Starpharma’s dendrimer nanotechnology to certain topical drugs.

Starpharma will receive staged payments with the completion of technical milestones within the collaborative project, the company said.

Starpharma also has dendrimer drug delivery programs under way in cancer and protein therapeutics.